Strategy
7 Problems with Traditional Neuromarketing That Hold Brands Back
Traditional neuromarketing isn't wrong. EEG, eye-tracking, and lab-based studies genuinely measure how the brain responds to creative — that part of the science holds up. The problem has never been the method. It's everything around it: the cost, the timeline, the access, and the fact that by the time results arrive, most of the decisions they were supposed to inform have already been made.
€30k–€250k
Typical cost per lab study
3–12 weeks
Typical time from brief to insight
1–2
Creative concepts most brands can afford to test
The Seven Structural Problems
High costs limit testing
A single EEG or eye-tracking study runs €30,000 to €250,000. That price puts traditional neuroscience out of reach for anything but flagship campaigns at the largest brands — smaller efforts, experimental directions, and early-stage concepts almost never get tested at all.
It takes too long
Recruiting participants, booking a lab, running sessions, and processing the data typically takes 3 to 12 weeks. That timeline doesn't match how fast creative decisions actually need to move.
It doesn't scale
Because it's expensive and slow, most brands can only afford to test one or two concepts — not the dozen variations that real iteration requires. Fewer tests means more good ideas quietly get missed.
Reading the results requires a specialist
EEG signals, gaze data, and emotional metrics don't interpret themselves. Most marketing teams don't have that expertise in-house, so they end up paying for outside consultants on top of the study itself.
Lab conditions aren't real conditions
A controlled room with a researcher watching isn't a living room, a commute, or a scroll through a feed. Participants behave differently when they know they're being observed, which means lab results don't always transfer cleanly to the real world.
People bias their own results
Even with perfect equipment, human participants introduce noise: overthinking their reaction instead of having it, softening an honest response to seem agreeable, or simply losing focus partway through a session. It's the same weakness that undermines focus groups and surveys.
It usually happens after launch
Most brands only bring in neuroscience once a campaign is already live — testing an ad or a package that's already in market. By then the media budget is already spent, and the research can describe what went wrong without being able to prevent it.
What Actually Fixes This
None of these seven problems are arguments against neuroscience. They're arguments against the infrastructure it's traditionally been delivered through. Fix the infrastructure, and the same rigor becomes something every team can use, not just the ones with a six-figure research budget.
Neuropredict runs on a €900–€5,500 monthly subscription instead of a per-study invoice, returns results in under 10 seconds instead of weeks, and puts no cap on how many concepts get tested — because the constraint was never the science, it was the delivery model.
- Affordable — subscription pricing replaces six-figure one-off studies
- Instant — full reports in under 10 seconds, not weeks
- Unlimited — every version, every iteration, every draft
- Pre-launch — catch the problem before media spend, not after
Conclusion
Traditional neuromarketing proved that measuring the brain's response to creative is worth doing. What it never solved was making that measurement fast, affordable, or available before a campaign goes live. Those are solvable problems — and solving them is what turns neuroscience from an occasional luxury into a routine part of how creative gets made.